FDA Final Export Rule Adds U.S. Corporate Official Certification Option
This article was originally published in The Gray Sheet
Executive Summary
Notification and recordkeeping requirements for exporters of unapproved devices and biologicals under sections 801 or 802 of the FD&C Act will allow U.S. corporate officials at the executive-VP level and higher to certify that products do not conflict with foreign laws, according to FDA